ESCRS - From the archive - Nitinol sutures ;
ESCRS - From the archive - Nitinol sutures ;

From the archive - Nitinol sutures

An injectable metal clip may reduce time spent constructing intraocular sutures by up to 20 times

From the archive - Nitinol sutures
Howard Larkin
Howard Larkin
Published: Friday, September 1, 2017
EuroTimes Volume 17 Issue 9, Page 60 First published September 2012
An injectable metal clip may reduce time spent constructing intraocular sutures by up to 20 times, greatly simplifying procedures including pupilloplasty, iris fixation of intraocular lenses, encircling band fixation and anchoring glaucoma drainage devices, Michael Erlanger MD told the innovators session of the ASCRS annual symposium. The circular, shape-memory titanium-nickel alloy 0.007-inch nitinol (nickel titanium alloy) suture wire is five times stronger than prolene and 38 times stronger than nylon. Proven in neurosurgery and cardiac stent applications, it is highly biocompatible and can be delivered one-handed through needles as small as 30 gauge for intraocular procedures. And unlike filament sutures, the wire clip can be bent and returned to its original shape, said Dr Erlanger, who is developing the technology at the University of Colorado, Denver, US, and has a patent pending on the injectable Nitinol suture with Jeffrey Olson MD. “This is very useful when you are working in the eye. You don’t have to use ocular gymnastics to get in a Seipser suture,” Dr Erlanger said. In animal tests, pupilloplasty was performed 16 times faster with the nitinol suture than with a modified Seipser slip knot, and the need for limbal-to-limbal passes was eliminated, making the procedure less technically challenging. Similarly, IOL iris fixation times were reduced 20-fold. When properly prepared, the titanium-nickel nitinol alloy is highly resistant to corrosion, Dr Erlanger noted. The compound has been used extensively in cardiovascular stents as well as orthopaedic and dental devices. BIOCOMPATIBLE While nitinol can be formed into any shape, for intraocular use a circular double-coiled clip may be most useful. Dr Erlanger has tested it in 0.5mm and 1.0mm suture sizes. He has developed an injector based on a syringe. Nitinol’s memory characteristics allow the suture to be straightened and injected through a straight or curved needle. It resumes its circular shape as it leaves the injector, allowing it to be anchored in tissue as it comes out. The suture can be manipulated with forceps after injection. Pre-set sutures can be sprung open to grasp haptics, glaucoma shunts, rings or other devices. In a three-month biocompatibility study involving five Yucatan mini pigs, five eyes receiving nitinol sutures and five receiving modified Seipser knots showed no significant differences in corneal specular cell counts, corneal thickness measured by OCT, corneal histology staining, or retinal histology measured by cell counts of the ganglion cell, inner nuclear and outer nuclear layers, Dr Erlanger reported (Inv Ophthalmol Vis Sci 2011). However, mean surgical time for the nitinol eyes was one minute 18 seconds compared with 19 minutes 38 seconds for the modified Seipser knot eyes (p<0.005). Other successful tests include anchoring an Ahmed glaucoma drainage shunt, Retisert fixation, installation of encircling bands and IOL fixation, Dr Erlanger said. He believes this technology will find broad application in ophthalmic surgery. EuroTimes Volume 17 Issue 9, Page 60 First published September 2012
Tags: from the archive
Latest Articles
From Lab to Life: Corneal Repair Goes Cellular

Long-awaited cellular therapies for corneal endothelial disease enter the clinic.

Read more...

Balancing Innovation and Safety

Ensuring access to advanced cell therapies amid regulatory overhaul.

Read more...

With Eyes on Its Future, ESCRS Celebrates Its Past

Winter Meeting offers opportunities to experiment with new concepts and formats.

Read more...

Best of ESCRS Winter Meeting 2024

Read more...

Following the New Generation

EDOF IOLs an option for eyes with mild comorbidities, showing potential in mini-monovision strategies.

Read more...

Refocus on Multifocals

Trifocal IOLs continue to improve as consensus grows regarding indications and contraindications.

Read more...

Common Myths in Presbyopia Correction

Patient education key to satisfaction with refractive IOLs.

Read more...

Reversible Multifocality

Two-lens combination offers low-risk spectacle independence for cataract patients and presbyopes.

Read more...

Managing a Cataract Surgery Refractive Miss

Weighing the pros and cons of options for intraocular intervention.

Read more...

Unleashing OCT’s Full Potential

Performance of newest tool for corneal evaluation meets or beats older standard technologies.

Read more...

;